Overview

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Status:
Terminated

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

Summary

The aim of this trial is to evaluate the impact on fat distribution of switching to NRTI-sparing regimens in lipoatrophic antiretroviral experienced patients with complete viral suppression. Maintenance of virological suppression and immunological factors are also assessed.

Phase:

Phase 4

Details

Lead Sponsor:

French National Agency for Research on AIDS and Viral Hepatitis

Treatments:

HIV Protease Inhibitors
Protease Inhibitors
Reverse Transcriptase Inhibitors